
A community oncology pharmacist explains how seeing patients across the course of their diagnosis builds trust and why accessibility remains the field’s biggest challenge despite advances in AI.
Achilles Alon, PharmD, RPh, Director of Specialty Pharmacy, Co-owner of ACE-Rx Specialty Pharmacy, discusses the potential for specialty pharmacies to become the norm.
Achilles Alon, PharmD, RPh, Director of Specialty Pharmacy, Co-owner of ACE-Rx Specialty Pharmacy, discusses the potential for specialty pharmacies to become the norm.
Transcript: That’s inevitable. It’s pretty close to that, I think, already. I think the number of specialty drugs that will—I think the amount of spend in [specialty] pharmacy in 2019 is expected to be over 50% of the spend in pharmacy in general. So, just by looking at these numbers, it’s hard to say that specialty pharmacy is not here to stay.